We have updated our forecasts on Oxford BioMedica this morning following the business update on 4 November 2015. Our LBT forecasts in our three year forecast horizon have been increased as the group continues to invest in expanding its business to support its manufacturing capabilities. 2015 has been a year the group has undertaken a substantial capex programme in order to increase its manufacturing space in order to deliver on its contract with Novartis and other potential customers. 2016 looks ....
